# Selenium Thyroid Fatigue Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/selenium-thyroid-fatigue-randomized-trial-evidence-review
Category: evidence-review
Summary: Selenium Thyroid Fatigue Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass a
Last reviewed: 2026-08-17
Reviewed by: Migaku Evidence Review
# Selenium Thyroid Fatigue Randomized Trial: What the Evidence Says

## Quick Answer

Selenium Thyroid Fatigue Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 narrative review, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Exploring the Comprehensive Treatment of Hashimoto&#8217;s Thyroiditis with Traditional Chinese Medicine from the Perspective of Modern Medicine | narrative review | 3 | 2026-02-06 | 10.2147/TCRM.S575059 |
| Beyond levothyroxine: a narrative review of adjunctive management strategies for Hashimoto&#8217;s thyroiditis | preclinical study | 4 | 2026-04-24 | 10.21037/gs-2025-1-554 |

## What The Sources Report

- However, the existing body of evidence is substantially constrained by methodological limitations, including small study scales, predominantly single-center designs, and a lack of standardized protocols. [Zhang Jing (2026); evidence level 3]
- This narrative review synthesizes contemporary understanding of the pathophysiology of HT and critically evaluates the scientific evidence supporting TCM interventions. [Zhang Jing (2026); evidence level 3]
- It is associated with elevated anti-thyroid peroxidase antibodies (TPOAb) and often anti-thyroglobulin antibodies (TgAb). [Personius Lydia (2026); evidence level 4]
- The incidence of HT has increased over recent decades and is higher with advancing age, in women, and in iodine-sufficient populations. [Personius Lydia (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For selenium thyroid fatigue randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Zhang Jing (2026). Exploring the Comprehensive Treatment of Hashimoto&#8217;s Thyroiditis with Traditional Chinese Medicine from the Perspective of Modern Medicine. DOI: 10.2147/TCRM.S575059. PMCID: PMC13029525. PMID: 41908912. License: https://creativecommons.org/licenses/by-nc/4.0/ https://www.dovepress.com/terms.php http://creativecommons.org/licens.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13029525/
- Personius Lydia (2026). Beyond levothyroxine: a narrative review of adjunctive management strategies for Hashimoto&#8217;s thyroiditis. DOI: 10.21037/gs-2025-1-554. PMCID: PMC13184362. PMID: 42164686. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13184362/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.